These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 26791842)

  • 1. Clinical Management of Uveal and Conjunctival Melanoma.
    Blum ES; Yang J; Komatsubara KM; Carvajal RD
    Oncology (Williston Park); 2016 Jan; 30(1):29-32, 34-43, 48. PubMed ID: 26791842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ocular melanoma: an overview of the current status.
    Jovanovic P; Mihajlovic M; Djordjevic-Jocic J; Vlajkovic S; Cekic S; Stefanovic V
    Int J Clin Exp Pathol; 2013; 6(7):1230-44. PubMed ID: 23826405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular melanoma.
    Char DH
    Surg Clin North Am; 2003 Apr; 83(2):253-74, vii. PubMed ID: 12744609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology and management of uveal melanoma.
    Yonekawa Y; Kim IK
    Hematol Oncol Clin North Am; 2012 Dec; 26(6):1169-84. PubMed ID: 23116575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular oncology: advances in retinoblastoma, uveal melanoma and conjunctival melanoma.
    Vasalaki M; Fabian ID; Reddy MA; Cohen VM; Sagoo MS
    Br Med Bull; 2017 Jan; 121(1):107-119. PubMed ID: 28069617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.
    Larsen AC
    Acta Ophthalmol; 2016 May; 94 Thesis 1():1-27. PubMed ID: 27192168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility of fluorescence in situ hybridisation (FISH) in diagnosis and therapy of ocular melanocytic lesions.
    Schauwvlieghe PP
    Bull Soc Belge Ophtalmol; 2008; (309-310):55-6. PubMed ID: 19198555
    [No Abstract]   [Full Text] [Related]  

  • 8. Uveal melanoma: From diagnosis to treatment and the science in between.
    Chattopadhyay C; Kim DW; Gombos DS; Oba J; Qin Y; Williams MD; Esmaeli B; Grimm EA; Wargo JA; Woodman SE; Patel SP
    Cancer; 2016 Aug; 122(15):2299-312. PubMed ID: 26991400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of ocular melanoma.
    Hungerford JL
    Br Med Bull; 1995 Jul; 51(3):694-716. PubMed ID: 7552089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular melanoma and the BAP1 hereditary cancer syndrome: implications for the dermatologist.
    Martorano LM; Winkelmann RR; Cebulla CM; Abdel-Rahman MH; Campbell SM
    Int J Dermatol; 2014 Jun; 53(6):657-63. PubMed ID: 24697775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanoma of the eye: revealing hidden secrets, one at a time.
    Shields CL; Kels JG; Shields JA
    Clin Dermatol; 2015; 33(2):183-96. PubMed ID: 25704938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and implications of TERT promoter mutation in uveal and conjunctival melanoma and in benign and premalignant conjunctival melanocytic lesions.
    Koopmans AE; Ober K; Dubbink HJ; Paridaens D; Naus NC; Belunek S; Krist B; Post E; Zwarthoff EC; de Klein A; Verdijk RM;
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):6024-30. PubMed ID: 25159205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selumetinib for the treatment of metastatic uveal melanoma: past and future perspectives.
    Komatsubara KM; Manson DK; Carvajal RD
    Future Oncol; 2016 Jun; 12(11):1331-44. PubMed ID: 27044592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological characteristics and clinical management of uveal and conjunctival melanoma.
    Kaštelan S; Pavičić AD; Pašalić D; Nikuševa-Martić T; Čanović S; Kovačević P; Konjevoda S
    Oncol Res; 2024; 32(8):1265-1285. PubMed ID: 39055896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uveal melanoma: A pathologist's perspective and review of translational developments.
    Schoenfield L
    Adv Anat Pathol; 2014 Mar; 21(2):138-43. PubMed ID: 24508696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of Ocular Melanoma: Insights into Genetics, Inheritance and Testing.
    van Poppelen NM; de Bruyn DP; Bicer T; Verdijk R; Naus N; Mensink H; Paridaens D; de Klein A; Brosens E; Kiliҫ E
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Uveal Melanoma.
    Shoushtari AN; Carvajal RD
    Cancer Treat Res; 2016; 167():281-93. PubMed ID: 26601868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic signaling in uveal melanoma.
    Park JJ; Diefenbach RJ; Joshua AM; Kefford RF; Carlino MS; Rizos H
    Pigment Cell Melanoma Res; 2018 Nov; 31(6):661-672. PubMed ID: 29738114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant conjunctival melanoma. Clinical review with recommendations for diagnosis, therapy and follow-up].
    Lommatzsch PK; Werschnik C
    Klin Monbl Augenheilkd; 2002 Oct; 219(10):710-21. PubMed ID: 12447715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on uveal melanoma: Translational research from biology to clinical practice (Review).
    Ortega MA; Fraile-Martínez O; García-Honduvilla N; Coca S; Álvarez-Mon M; Buján J; Teus MA
    Int J Oncol; 2020 Dec; 57(6):1262-1279. PubMed ID: 33173970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.